Skip to main content

EPA Aims to Drastically Reduce Animal Testing

The agency plans to stop funding virtually all toxicology studies in mammals by 2035.

Written byEmily Makowski
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

Yesterday (September 10), the Environmental Protection Agency announced that it will stop conducting or funding studies that involve testing on mammals by 2035. EPA administrator Andrew Wheeler says in a news release that the agency aims to reduce the money that goes to such experiments by 30 percent by 2025 and eliminate testing on mammals altogether by 2035. After that, any research using mammals requested or funded by the EPA will need administrator approval.

The move drew mixed reactions. Some praised it as a step forward for animal rights. “Animal testing is often cruel and painful, with limited applicability to human health outcomes. Non-animal research is more accurate, more cost effective, and more humane,” Congressman Matt Gaetz (R-FL) says in the EPA’s news release.

Others say the announcement was premature and could potentially expose humans to harmful chemicals. Ending experiments on mammals “is going to allow potentially dangerous chemicals to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays